Expression and Content of Protein LC3B in Gastric Cancer Tissue, Relationship with Expression of mTOR, AMPK in Gastric Cancer Tissue and HER2 and PD-L1 Status of the Tumor

Bull Exp Biol Med. 2021 Dec;172(2):202-205. doi: 10.1007/s10517-021-05376-0. Epub 2021 Dec 2.

Abstract

Analysis of HER2 status of the tumor and expression of mTOR, AMPK showed a decrease in mTOR mRNA level in HER2+ tumors in comparison with HER- status. The appearance of PD-L1+ transformed cells in the tumor was associated with increased expression of the LC3B gene and elevated content of the corresponding protein measured after treatment.

Keywords: HER2 tumor status; LC3B; PD-L1 tumor status; gastric cancer.

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism
  • Adenocarcinoma* / diagnosis
  • Adenocarcinoma* / drug therapy
  • Adenocarcinoma* / genetics
  • Adenocarcinoma* / metabolism
  • Antineoplastic Agents / therapeutic use
  • B7-H1 Antigen / genetics
  • B7-H1 Antigen / metabolism
  • Biomarkers, Pharmacological / metabolism
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Microtubule-Associated Proteins* / genetics
  • Microtubule-Associated Proteins* / metabolism
  • Prognosis
  • Receptor, ErbB-2 / genetics
  • Receptor, ErbB-2 / metabolism
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / drug therapy
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / metabolism
  • TOR Serine-Threonine Kinases / genetics
  • TOR Serine-Threonine Kinases / metabolism
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • B7-H1 Antigen
  • Biomarkers, Pharmacological
  • Biomarkers, Tumor
  • CD274 protein, human
  • MAP1LC3B protein, human
  • Microtubule-Associated Proteins
  • MTOR protein, human
  • Receptor, ErbB-2
  • TOR Serine-Threonine Kinases
  • AMP-Activated Protein Kinases